| Breakdown | TTM | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 340.70M | 361.00M | 342.65M | 264.10M | 230.11M | 185.14M |
| Gross Profit | 189.00M | 203.90M | 194.59M | 136.91M | 116.93M | 95.52M |
| EBITDA | 43.80M | 50.20M | 55.25M | 38.54M | 32.68M | 25.81M |
| Net Income | 22.60M | 25.40M | 32.30M | 20.24M | 16.89M | 13.70M |
Balance Sheet | ||||||
| Total Assets | 364.20M | 385.30M | 371.74M | 315.11M | 289.24M | 259.16M |
| Cash, Cash Equivalents and Short-Term Investments | 17.10M | 40.60M | 65.75M | 51.54M | 41.23M | 54.47M |
| Total Debt | 30.00M | 32.40M | 8.90M | 10.65M | 12.23M | 12.94M |
| Total Liabilities | 156.40M | 170.50M | 169.29M | 127.28M | 120.27M | 90.91M |
| Stockholders Equity | 207.80M | 214.80M | 202.45M | 187.84M | 168.97M | 168.25M |
Cash Flow | ||||||
| Free Cash Flow | 16.20M | 35.70M | 31.78M | 20.26M | 31.86M | 19.36M |
| Operating Cash Flow | 17.80M | 41.90M | 37.62M | 26.88M | 39.85M | 25.13M |
| Investing Cash Flow | -6.30M | -69.90M | -4.61M | -6.87M | -30.90M | -5.83M |
| Financing Cash Flow | -31.70M | 3.20M | -16.93M | -12.77M | -22.99M | 4.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £450.35M | 7.41 | 10.70% | 3.26% | -11.68% | -40.06% | |
73 Outperform | £43.54B | 26.83 | 70.68% | 2.13% | 2.48% | 3.23% | |
65 Neutral | £5.86B | 20.41 | 11.94% | 2.32% | -0.82% | 30.81% | |
63 Neutral | £370.92M | 10.45 | 6.22% | 0.53% | -6.22% | -6.69% | |
62 Neutral | £9.54B | 32.17 | 1.20% | 2.34% | 15.73% | -76.05% | |
62 Neutral | £198.19M | -1.32 | -21.91% | 11.37% | -4.44% | 19.95% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |